What is the difference between Cerluten and Vesugen?

Cerluten: CNS-targeted peptide complex that modulates neuronal gene expression. Shown in Russian clinical studies to improve memory consolidation, attention, and protect against neurodegeneration. Vesugen: Tripeptide bioregulator targeting vascular endothelium; normalizes gene expression in smooth muscle and endothelial cells; reduces lipid accumulation in vessel walls

Is Vesugen FDA approved?

Vesugen is not evaluated or approved by the FDA. It is discussed for research and educational purposes only, not as medical guidance.

How is Cerluten administered in research settings?

In research settings, Cerluten is typically administered via the oral or subcutaneous routes. PeptideBase does not provide dosing or administration instructions.

How is Vesugen administered in research settings?

In research settings, Vesugen is typically administered via the subcutaneous or oral routes. PeptideBase does not provide dosing or administration instructions.

Home›Research›Compare›Cerluten vs Vesugen

Peptide Comparison

Cerluten vs Vesugen

Name: Cerluten vs Vesugen — Per-mg Price Comparison
Creator: PeptideBase
License: https://peptidebase.io/terms

Both are Longevity & Cellular peptides.

Cerluten

brain peptide bioregulator

LongevityResearch Only

1 providers listed

Full Cerluten profile →

Vesugen

Lys-Glu-Asp

LongevityNot EvaluatedResearch Only

Half-life: Unknown

2 providers listed

Full Vesugen profile →

Bottom line

Vesugen is carried by more providers on PeptideBase (2 vs 1); otherwise the two are closely matched on the measures we track.

Quick Verdict

Cerluten

Evidence

Review-level

Vesugen

Evidence

Review-level

Which One Should You Choose?

Your goal	Better option
More provider options (1 vs 2)	Vesugen

Research summary only — not medical advice. Consult a qualified provider before making any decisions.

Side-by-Side Comparison

Cerluten

Vesugen

Mechanism Family

Longevity & Cellular

Half-life

—

Unknown

FDA Status

unknown

not evaluated

Admin Routes

oral, subcutaneous

subcutaneous, oral

Availability

Research Only

Providers

1 listed

2 listed

Avail. Notes

—

Russian vascular peptide bioregulator (Lys-Glu-Asp) from Khavinson Institute. Developed for vascular endothelium health. Not FDA-approved. Not on any FDA list. Research chemical.

Research Evidence

Cerluten

Review-levelReview · 2 key studies · most recent 2022

Vesugen

Review-levelReview · 2 key studies · most recent 2021

Research Citations

Cerluten

Review2022 · International Journal of Molecular Sciences

Peptide Regulation of Gene Expression and Protein Synthesis in Bronchial Epithelium

Review2021 · Molecules

Peptide Regulation of Gene Expression: A Systematic Review

Vesugen

Review2021 · Molecules

Peptide Regulation of Gene Expression: A Systematic Review

Review2020 · Stem Cell Reviews and Reports

Short Peptides in the Treatment of Age-Related Diseases

About Cerluten

CNS-targeted peptide complex that modulates neuronal gene expression. Shown in Russian clinical studies to improve memory consolidation, attention, and protect against neurodegeneration.

Research Areas

neuroprotectioncognitive supportmemoryanti-aginglongevity

About Vesugen

Tripeptide bioregulator targeting vascular endothelium; normalizes gene expression in smooth muscle and endothelial cells; reduces lipid accumulation in vessel walls

Research Areas

vascular repairendothelial functioncardiovascular anti-agingatherosclerosis reduction

Safety Profile

Information below reflects published research data only — not medical advice. Consult a qualified provider before use.

Cerluten

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Vesugen

No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.

Price (per mg)

Cerluten

Not enough vendor pricing yet.

Vesugen

$2.75/mg

$2.00 – $3.00 range

5 vendors

View price index →Find providers →

Find Providers

Where to source these peptides

Providers offering

Cerluten

1 listed

Browse directory →

Providers offering

Vesugen

2 listed

Browse directory →

PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.

More Longevity & Cellular Comparisons

Browse all peptides →

Educational research tools — not medical advice.

Cite this page

Data last updated July 20, 2026

Free to reference and republish with attribution to PeptideBase. Choose a format:

PeptideBase. (2026). Cerluten vs Vesugen — Per-mg Price Comparison. Retrieved July 22, 2026, from https://peptidebase.io/peptides/compare/cerluten/vesugen

https://peptidebase.io/peptides/compare/cerluten/vesugen Methodology License Download JSON Download CSV